A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...
Among people prescribed antipsychotics on the NHS for a diagnosis of severe mental illness, people from ethnic minority backgrounds and those from deprived areas in the UK are prescribed higher doses, ...
Although antipsychotics were developed to treat schizophrenia, newer ones are sometimes used to treat depression that has not been relieved by antidepressants or other treatments. Depression is a ...
Recently, second-generation antipsychotics (SGAs), olanzapine plus fluoxetine, quetiapine extended release and aripiprazole have clearly demonstrated efficacy in the treatment of MDD patients ...
For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...
Kennedy Jr.’s confirmation as health secretary, President Donald Trump instructed his administration to assess the “threat” posed to children by the prescription of selective serotonin reuptake ...
conventional agents All-cause mortality as recorded in the Registered Persons Database or the Discharge Abstract Database New use of atypical antipsychotics associated with SS increase in the risk ...
We analysed data from 7,216,791 people aged three to 18 years old. In the UK, antipsychotics, also known as “major tranquillisers”, are approved for use in under-18s with psychosis or with severely ...
In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia.
A third of people with schizophrenia have symptoms that will not sufficiently respond to two adequate trials of antipsychotic medications.1 For these people with treatment-resistant schizophrenia, ...
Triple knife killer Valdo Calocane was not forced to take long-lasting antipsychotics because he did not like needles, a damning report outlining a litany of failings in his care has revealed.